Perspective from Industry: Deep Visual Proteomics and Quantitative Assays
Deep visual proteomics and quantitative proteomic assays are expanding the possibilities for understanding disease biology and translating discoveries into actionable insights. By combining spatially resolved proteomics with robust quantitative workflows, researchers can gain a more comprehensive view of complex biological systems.
In this webinar, our speakers will share perspectives on the application of deep visual proteomics and quantitative assays in translational and biomedical research. Join us to learn how advanced proteomic workflows can help uncover biologically relevant targets, improve analytical confidence, and support the generation of high-quality data at scale.
Precision at the Microscale: Low Input Spatial Proteomics in the 5xFAD Brain
- T. Wolf, Post Doc, Drug Safety R&D, Pfizer
Using the Evosep Eno and Orbitrap Astral Zoom, we applied a spatial proteomics workflow integrating AI-driven image segmentation with low-input mass spectrometry. This high-resolution pipeline reliably captured 5xFAD brain microenvironments, resolving distinct local proteomes to reveal diverging pathological pathways between plaques and microglial subtypes.
Reimagining Large Molecule PK Analysis with High-Throughput Evosep ENO LCMS
- Rebecca Ferreira, Senior Associate Scientist, Pfizer
Accelerate biologics discovery with high-throughput LCMS. Learn how the Neubert Group at Pfizer is using the Evosep ENO platform to improve PK assay throughput while maintaining sensitivity and robustness needed for surrogate peptide quantification, enabling faster construct selection and optimization.
